Conference Information

Welcome Message

_{Welcome Message}

Greetings,

We are pleased to announce the “International Conference on Cancer Research and Treatment” Scheduled on December 07-09, 2023 in Madrid, Spain. The conference will be organized around the theme "Latest developments and the forecast for cancer research and treatment".

We are delighted to extend an appeal to you to undergo cancer conferences 2023, which will maximize attendees and speakers during professional and social interactions that are just as important as the sessions themselves.

Our objective is to present an excellent program that covers the whole range of cancer research and breakthroughs, encourages top-level of oncology research, and focuses on the field's current exceptional accomplishments as well as future trends and requirements. The system's most current research and technology are discussed in detail.

The goal of cancer conferences 2023 is to advance knowledge and fresh concepts among professionals, academics, and academics working in the disciplines of cancer research and treatment. In vibrant discussions throughout the program, participants will discuss their discoveries and interests. Together with the usual plenary, keynote, and oral abstract sessions, the program will also feature educational lectures, interactive workshops, and hands-on activities.

Welcome you all to the cancer research and treatment conference 2023!!

Regards
Organizing Committee
Cancer Conference 2023

Important Deadlines

Make a note of the following beneficial Cancer Conference 2023 deadlines.

Conference Dates: December 07-09,2023
Early Bird Registration Deadline: August 20, 2023
Abstract Submission Deadline: August 15, 2023
Abstract Acceptance/ Rejection: 24-48 hours

Group Registrations Waivers Available

10% Waiver: 3-5 Members
15% Waiver: 6-10 Members
20% Waiver: 11-15 Members
25% Waiver: 16+Members

Kindly contact Celena Christopher (Senior Program Manager) for further assistance via,

WhatsApp: +44 738 964 3966
Email: cancer@pulsusgathering.org

About Conference

Oncology and Cancer Conferences 2023 - is a tremendous achievement in the field of cancer research and therapy that, as said, helped the attendees obtain the right ideas. The most illustrious individuals in the area planned the cancer conference, which was held in Madrid, Spain. The participation of several eminent speakers helped the cancer research conference grow to be a huge success.

After the overwhelming response to the oncology and cancer conferences in 2023, we are now prepared to turn cancer conferences 2023 into a resounding success! Opportunities for cancer research conference Attendees.

The specialists' points and experiences related to medical procedures, cancer, for the lung cancer, breast cancer and the bridge for blood cancer. The group of chemotherapy for an prostate cancer between to radiotherapy and Immunotherapy, and other topics will be relevant in the cancer conference 2023.

The primary objective of the gathering is to examine the most recent findings in oncology and cancer research treatment methods together with protected, compelling, and reasonable usage. To develop speculative and practical skills, the speakers and agents explore the material through paper shows, banner shows, speaker gatherings, and presentations by dynamic professionals.

Why to attend?

Meet experts and influencers in the Clinical cancer Conferences 2023. The goal of the cancer research conference is to discuss, disseminate and preserve knowledge in preventing and treating cancer. It gives innovators the opportunity to bridge the gap between development and adoption. At this three-day event, you can give presentations, disseminate information, meet current and potential scientists, gain attention with new discoveries in oncology, Blood Cancer and gain fame. Participants will have direct access to a select group of experts and decision-makers

KEY FACTS:

One in six fatalities, or around 10 million deaths, will be due to cancer in 2020, making it the top cause of death globally.
Cancers of breast cancer, Prostate Cancer, and lung cancer are the most prevalent types of cancer.
Tobacco use, a high body mass index, alcohol usage, a poor diet heavy in fruits and vegetables, and a lack of exercise account for around one-third of cancer-related fatalities.
Around 30% of cancer cases in low- and lower-middle-income nations are caused by cancer research causing infections, such the human papillomavirus (HPV) and hepatitis.
If identified early and successfully treated, many cancers are curable.

Who Should Attend:

Oncologists
Pathologists
Health Care Professionals
Medicine Manufacturing Companies
Medical Colleges
Breast Cancer Associations and Societies
Students and Delegates
Radiologists
Chemotherapists
Physicians
Business Entrepreneurs
Medical Device Manufacturing Companies
Diagnostics Companies

Target Audience:

Oncologists
Researchers
Professors
Directors
Pediatric Oncologists
Scientists
Exhibitors
Young Researchers
Cancer Institutes
Medical Institutes
Chemotherapists
Pharmacists

WHY CANCER RESEARCH IS IMPORTANT:

Cancer research is important because the better we understand these diseases, the more progress we will make toward diminishing the tremendous human and economic tolls of cancer.

Research has helped us accumulate extensive knowledge about the biological processes involved in cancer and oncology onset, growth, and spread in the body. Those discoveries have led to more effective and targeted treatments and prevention strategies.

Breakthroughs in prevention, early detection, screening, diagnosis, and treatment are often the result of cancer research and discoveries made by scientists in a wide array of disciplines over decades and even generations. Ultimately, cancer research requires partnerships and collaborations involving researchers, clinicians, patients, and others to translate yesterday’s discoveries into today’s advances and tomorrow’s cures.

Specialists & Educators:

Speaker Presentations
Poster Display
Symposium hosting
Workshop organizing

Students & Research Scholars:

Poster Competition
Young Researcher Forum
Student Attendee
Group Registrations

Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

Companies:

Exhibitor and Vendor Booths
Sponsorship
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

Market Analysis

The Worldwide cancer and oncology market was estimated to be worth US$ 286.04 billion in 2021 and is projected to expand to more than US$ 581.25 billion by 2030, with a notable CAGR of 8.2% predicted to occur between 2022 and 2030.

Key Takeaway:

In 2021, the cancer research diagnostic market category accounted for 46.8% of the overall market share.
From 2022 to 2030, the hospital sector is expected to increase at a CAGR of 10.9%.
Market revenue for breast cancer was estimated at USD 57.23 billion in 2021.
In 2021, the North American region had 46.2% of the market.

List of some sales data that illustrates the recent rapid rise of oncology:

The cancer research and treatment segment accounted for approximately 56% of the global oncology market share in 2020.
Around 19.3 million new cancer cases and around 10 million cancer-related deaths were registered in 2020.
New cancer cases are anticipated to rise by 47% from 2020 to 2040, across the globe.
Approximately 1.8 million deaths were attributed to lung cancer.
In 2020, breast cancer accounted for over 2.3 million cases or 11.7% of all new cancer cases.

Growth Agents :

The worldwide cancer and oncology market is expanding as a result of the growing cancer conference 2023 burden globally caused by rising alcohol and cigarette use. In its GLOBOCAN report, the International Agency for Research on Cancer (IARC) estimates that there were roughly 19.3 million new cases of cancer and 10 million cancer-related deaths worldwide in 2020. According to the IARC, global new cancer cases are predicted to increase by 47% between 2020 and 2040.

Thus, it is anticipated that the rising incidence of cancer would encourage the use of oncology diagnostics and oncology treatments everywhere, thereby fostering the expansion of the worldwide cancer conference 2023 market. Additionally, it is anticipated that the market would rise as a result of increased government and non-profit activities to raise awareness about cancer prevention. For instance, the Global Action Plan for Prevention and Control of Non-Communicable Diseases of the World Health Organization seeks to reduce the number of preventable deaths from diabetes, Lung cancer, prostate cancer, cardiovascular disease, and other chronic respiratory illnesses by around 25% by the year 2025. The need for early cancer diagnosis and treatment has increased due to the growing frequency of numerous chronic illnesses.

The biopharmaceutical sector's growing investments and innovations are promoting the creation of a variety of novel medications and therapies, which in turn is boosting demand for cancer research treatments and oncology diagnostics in the cancer conference 2023. The increased public knowledge of the availability of different oncology-related medications and diagnostics is anticipated to propel the expansion of the global oncology market. 20% of pharmaceutical sales worldwide are accounted for by cancer therapies alone. As a result, the oncology sector is attracting investors due to its growing relevance and increasing profit potential.

The extent of the pipeline of treatments now undergoing clinical testing, the introduction of novel pharmacological ingredients, the increasing number of oncology-related clinical studies, the investments made by firms in cancer medicines, and the growing interest in cancer

Study of the cancer therapy market

In 2020, the market for cancer therapies was estimated to be worth over USD 158 billion. By 2026, it is participated to generated USD 268 billion in sales, growing at a CAGR of 9.15%.

Market analysis of cancer therapies:

Global healthcare systems and the market for cancer therapies have both been significantly impacted by the COVID-19 pandemic. The six most prevalent cancer types are breast cancer, immunotherapy, chemotherapy, blood cancer, colorectal, lung cancer, pancreatic, gastric, and esophageal cancer saw a 46% decline in diagnoses during the COVID-19 pandemic, according to a study published in Cancer Network 2020 by physicians from the Dana Farber Cancer conference 2023 Institute. Also, numerous professional groups within the medical industry, including the Centers for Disease Control and Prevention (CDC), advised cancer screening and others to protect the hospital's infrastructure for the care of COVID-19 patients, health preventative services and elective procedures should be delayed until the dangers outweigh the benefits. Consequently, the market for cancer research therapy has been influenced by the COVID-19 pandemic. Yet, it is anticipated that things will get better with time.

Segment Review by Region :

Due to its large patient population, strong key player presence, ease of drug availability, well-developed healthcare infrastructure, healthcare expenditure in the healthcare system, higher number of research, development, and innovation activities, and higher adoption of advanced therapeutics, North America accounted for the largest share of cancer research revenues in 2020 and is predicted to maintain its dominance from 2021 to 2030. Nevertheless, due to an increase in the number of people with cancer and a growth in awareness of various cancer conference 2023 in malignancies, Asia-Pacific is predicted to expand at the greatest CAGR.

Top cancer research organization :

Top campaigns between 2020 to 2023 :

Session / Tracks

Session 1: Immunology

A major area of the biological and medical sciences, immunology is the study of the immune system. Our immune system defends us against infection via a number of different mechanisms. Diseases including cancer, allergies, and autoimmunity can develop if the immune system is not working properly.

Several medical specialties, including rheumatology, virology, allergology, bacteriology, cancer, and transplantation medicine, all benefit from the study of immunity.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Journal of Clinical Oncology, Clinical Cancer Research, Cancer Journal for Clinicians, Journals of Oncology Conferences 2023, Journal of Thoracic Oncology, European Journal of Cancer, British Journal of Cancer, Cancer Immunology, Immunotherapy Conferences and Cancer Research Conferences and Treatment

Session 2: Oncology

The study, treatment, diagnosis, and prevention of cancers are the objective of the branch of medicine designated as oncology. Oncologists are doctors that specialize in cancer treatment.

Medical Oncology
Surgical Oncology
Clinical Oncology
Radiation Oncology
Neuro-Oncology
Computational Oncology
Exercise Oncology

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 3: Carcinoma

Carcinoma makes up 80% to 90% of all cancer diagnoses, making it the most common kind of cancer. Epithelial tissue, which borders your organs, internal body passages, and skin, is where cancerous tumors develop. Tumors known as carcinoma can develop on your skin, in your lungs cancer, breasts, prostate cancer, colon, kidneys, pancreas, and other organs.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 4: Cancer Biology

A wide range of illnesses that all have their roots in unchecked cellular development is together referred to as cancer. Cancers are further defined and categorized by their cell type, tissue, or organ of origin, broadly categorized as benign tumors (unable to spread) or malignant tumors. Second, only to heart disease, cancer is still the second leading cause of death in the United States. The Intramural Research Program (IRP) is dedicated to promoting research, developing expertise, and maximising resources to meet this worldwide concern. Our scientists care about discovering new and improved methods to prevent, detect, and cure cancer. They are always learning more about the origins of the disease.

Biological molecular
Cellular biology
Carcinogenesis Immunology
Biostatistics
Genomic medicine and clinical genetics
Epidemiology

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 5: Lung Cancer

A malignant tumor that starts in the lung is referred to as lung cancer or lung carcinoma. Lung cancer is brought on by genetic damage to the DNA of airway cells, which is frequently aggravated by cigarette smoking or breathing carcinogenic substances. It is possible for damaged airway cells to proliferate unregulated and develop into a tumour. Lung tumors can spread throughout the lung if they are not treated, impairing lung function. Lung tumours eventually develop metastases, which spread to other areas of the body and result in a variety of diseases. According to the cells they develop from, lung tumours are categorised. Small-cell lung cancers make up around 15% of cases, whereas adenocarcinomas, squamous-cell carcinomas, and large-cell carcinomas make up the remaining 85%.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 6: Breast Cancer

So many parts of the breast might act as the origin for breast , tumors. The organ known as the bosom is located over the upper ribs and chest muscles. Everyone has a left and right breast, which are mostly made up of greasy tissue, conduits, and organs. In women, the bosom produces and transports milk to care for infants and young children. Each breast's size is determined by the amount of oily tissue in the bosom. The illness phase affects the treatment. Chemotherapy, radiotherapy, chemical therapy, and medical procedures might be included.

Breast cysts
Fibro adenomas
Fibrocystic breast changes
Hyperplasia
Intraductal papilloma
Mammary duct ectasia
Traumatic fat necrosis

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 7: Blood Cancer

The production and functionality of blood cells are both impacted by blood cancer. The soft, sponge-like substance in the middle of your bones called bone marrow is where the majority of blood malignancies begin. Your bone marrow produces stem cells that develop into platelets, white blood cells, and red blood cells.

Normal blood cells regulate bleeding, transport oxygen throughout the body, and fight infection. When anything interferes with how your body produces blood cells, blood cancer results. When you have blood cancer, abnormal blood cells outnumber healthy blood cells, which leads to a cascade of illnesses. When medical professionals discover novel treatments for blood cancer, more people are surviving longer with the disease.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 8: Biomarkers

Biomarker testing is a method of searching for genes, proteins, and other chemicals known as biomarker or tumor markers that can reveal information about cancer. Each person's cancer its has an own set of biomarkers. Certain biomarkers impact how cancer treatments succeed. Biomarker testing may assist you and your doctor in determining the best cancer treatment for you.

Several types of biomarkers can also assist doctors in diagnosing and monitoring cancer research during and after therapy. Visit the Tumor Markers information sheet to learn more.

Biomarker testing is only for cancer patients. Biomarker testing is available for persons with solid tumours and blood cancer.

Tumor testing
Tumor genetic testing
Genomic testing or genomic profiling
Molecular testing or molecular profiling
Somatic testing

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 9: Metastatic

Cancer that has migrated outside of its original site to other, distant locations of the body is referred to as metastatic cancer. We'll define metastasis first in order to completely comprehend metastatic cancer.

The term "Metastasis" is used to explain how cancer spreads. Cancer research cells, in contrast to normal cells, have the capacity to develop outside of the region of your body from where they started. Metastatic cancer, advanced cancer, or Stage IV cancer are terms used to describe this situation.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 10: Prostate Cancer

The male reproductive system includes the prostate cancer and seminal vesicles. The prostate is comparable to a walnut in size. Two more compact pairs of glands, known as seminal vesicles, are joined to the prostate's back. In front of the rectum, below the bladder, is the prostate. It encircles the urethra, a tiny tube that exits the bladder through the penis and contains urine.

The prostate cancer and seminal vesicles' primary function is to produce fluid for semen. The urethra is where the sperm travels during ejaculation. The seminal vesicles and the prostate's fluid both enter the urethra at the same moment. Semen is a combination that exits the penis as ejaculates after passing through the urethra.

heavy pain in the area of the lower pelvis
frequent urge to urinate
weak urine flow, discomfort, burning, or difficulty passing urine
Urine with blood in it hematuria
painful ejaculation

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 11: Tumors

Tumors develop when aberrant brain cells proliferate. Tumors can be classified into two categories: malignant tumors and benign (non-cancerous) tumors. They can also be divided into two categories: primary tumors, which originate inside the brain, and secondary tumors, or brain metastasis tumors, which often have spread from cancers outside the brain. Depending on the tumor size and the section of the brain it affects, symptoms from all forms of brain tumors might differ. If symptoms are present, they may include migraines, convulsions, visual issues, vomiting, and mental disturbances. Additional symptoms might include inability to talk, walk, feel things, or be unconscious.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 12: Chemotherapy

A chemotherapy regimen is a chemotherapy programme that specifies the medications to be used, their dose, the frequency and length of treatments, and other factors. Several chemotherapy regimens in contemporary oncology include several chemotherapy agents in combination chemotherapy. The vast majority of cancer chemotherapy medicines are cytostatic, with several causing cytotoxicity.

A core tenet of medical oncology, including combination chemotherapy, is that various medications function through distinct pathways, and that the consequences of employing many treatments will be synergistic to some level. They can be administered concurrently at full doses in chemotherapy regimens since they have different dose-limiting adverse effects.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 13: Radiotheraphy

Radiotheraphy is one of the cancer research treatment options. The procedure includes the deposition of energy in the targeted cells by ionizing radiation, resulting in cell death and the cessation of cell development. To decrease a malignant tumor, radiotherapy might be utilized as a primary therapeutic option before surgery. It can also be used after surgery to inhibit the development of any leftover cancer cells, in conjunction with chemotherapy, or to relieve cancer-related symptoms.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 14: Liver Cancer

Liver cancer is a kind of cancer that begins in the liver. Liver cancer can be primary or secondary has spread from elsewhere to the liver, known as liver metastasis. Liver metastasis is more prevalent than primary liver metastasis. Globally, there is an increase in liver cancer.

Cirrhosis caused by hepatitis B, hepatitis C, or alcohol is the major cause of liver cancer. Aflatoxin, non-alcoholic fatty liver disease, and liver flukes are some of the other reasons. HCC, which accounts for 80% of cases, and intrahepatic cholangio carcinoma are the most prevalent kinds. Blood tests and medical imaging may be used to support the diagnosis, and tissue biopsy may be used to confirm it.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 15: Hyperthermia

Hyperthermia is a type of therapy in which bodily tissue is heated to temperatures as high as 113 degrees Fahrenheit to help damage and kill cancer cells while causing little or no injury to normal tissue. Learn about the many forms of cancer and pre-cancers that hyperthermia is used to treat, how it is administered, and the positive and negative aspects of utilizing hyperthermia.

Heat cramping
Syncope due to heat
Exhaustion from the heat
Heat exhaustion

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 16: Thyroid Cancer

Thyroid cancer is cancer that arises from thyroid gland tissues. It is a disorder in which cells develop improperly and can spread to other regions of the body. Swelling or a bump in the neck might be symptoms. Cancer can sometimes expand to the thyroid after it has spread elsewhere, in which case it is not categorised as thyroid cancer.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 17: Biopsy

In the hope of investigating a small sample of bodily tissue under a microscope, doctors use a technique called a biopsy.

Anything on or inside of your body, including the skin, organs, and other structures, can be used to collect a tissue sample. The word "biopsy" is frequently used to describe both the procedure for collecting the sample and the actual tissue sample.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Session 18: Cancer drugs and vaccion

Anti-cancer medications can be more effectively delivered and cancer research and treated when combined with nanomaterials, and the processes behind this interaction have been studied. The difficulty of delivering cancer drugs to diseased regions has accelerated the development of Nano medicine. Here, we provide an overview of encouraging research about cancer therapies based on Nano-drug delivery vectors. Uncoated nanoparticles have relatively significant toxicity, which limits their application in humans. Many strategies have concentrated on encasing nanoparticles in biocompatible materials to lessen toxicity. Nanoparticles loaded with a high dose of a cancer medicine were used in effective delivery systems in the presence of bilayer molecules. Drug delivery systems with precise bonding have been developed using well-established nanotechnologies. Surface-modified nanoparticles used as medication delivery systems.

Related Conferences:

Related Societies:

Related Associations:

Related Journals:

Metrics

Pulsus Group is one of the world’s remarkable Scientific Conference Organizers who have their individuality on all the spectrums of Science, Technology and Business. A part of every conference series’ success specifically hangs on to how far it reaches the online community. Having an online audience is critical to make an international gathering a great success be it cancer research or academic.

Oncologists like medical oncologists, surgical oncology, radiotherapy, lung cancer, Gynaecologic oncologists, chemotherapy, pediatric oncologists, breast cancer, neuro-oncologists, blood cancer, cancer biology, hematologist, prostate cancer, Academicians, immunotherapy, Research institutes, Industrialists and students are the primary participants in attending the Pulsus conference series on Oncology and cancer as represented in the below-quoted metrics. Conferences based on the study, diagnosis, treatment, and prevention of cancer and its related studies show a significantly large number of unique visitors and page views which proved to be a thriving success.

Pulsus further extends its frontier by maintaining every cancer conference proceeding on its respective conference web pages and its official social media accounts. Thus, aspiring to have the participation of the international scientific and industrial communities to come and experience the pack of talks, discussions, product exhibitions, and alliances.

19 Conference Highlights

Oncology Cancer Biology Breast Cancer Thyroid Cancer Tumors Cancer Drugs and Vaccine Blood Cancer Biopsy Oral and Oropharyngeal cancer Lung Cancer Liver Cancer Metastatic Prostate Cancer Chemotherapy Radiotherapy Biomarkers Carcinoma Immunology Hyperthermia

ðŸŽ—ï¸Calling all cancer warriors!

Don't miss the #cancerconference2023

Register your group now and get a fantastic 10% discount.

Join experts, patients, and advocates in the fight against cancer.

Limited offer, so act fast! #GroupRegistration #CancerWarriors #Madrid #Spain pic.twitter.com/9qAV8q6yBh
— Cancer Conference 2023 (@ICCRT_2023) August 4, 2023